Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs

Abstract Introduction This open-label study evaluated the immunogenicity, safety, and efficacy of sarilumab monotherapy in patients with active, moderate-to-severe rheumatoid arthritis (RA) and inadequate response or intolerance to prior conventional synthetic disease-modifying antirheumatic drugs....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Alvin F. Wells, Janie Parrino, Erin K. Mangan, Anne Paccaly, Yong Lin, Christine Xu, Chunpeng Fan, Neil M. H. Graham, Hubert van Hoogstraten, Albert Torri
Médium: Artigo
Jazyk:Inglês
Vydáno: Adis, Springer Healthcare 2019-05-01
Edice:Rheumatology and Therapy
Témata:
Arthritis
Biological DMARDs
Rheumatoid arthritis
On-line přístup:http://link.springer.com/article/10.1007/s40744-019-0157-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky